Indiana Biosciences Research Institute Launches New Website to Further Advance Its Mission

INDIANAPOLIS (January 8, 2026) – The Indiana Biosciences Research Institute (IBRI), a first-in-class translational medicine institute, launches a new website to highlight its growing impact and enable deeper engagement with partners, supporters, donors, and the broader life sciences community.

By connecting early-stage biotech companies with cutting-edge life science discoveries—and backed by the mission and resources of industry leaders, investors, and philanthropic partners—IBRI is successfully evolving a new, independent model to conquer disease, uniting previously fragmented forces in the quest for cures.

The website launch follows a recent evolution of IBRI’s brand, reflecting the organization’s mission to be a catalyst for scientific discovery and transformative solutions. “Our website is often the front door to IBRI for our partners around the world,” said Christopher Conway, IBRI Executive Vice President, Communications and Chief Philanthropy Officer. “It is a living platform that will continue to evolve as we share new initiatives, insights, and breakthroughs.”

Designed with clarity and innovation in mind, the new website brings together information about IBRI’s projects, research pipeline, and opportunities for collaboration, mentorship, and philanthropic support. Together, these updates help stakeholders better understand the work being done and the outcomes it drives.

The new site reinforces IBRI’s commitment to clear communication and continuous improvement as it advances research that leads to better medicines and healthier lives.

For more information on IBRI and to view the site, please visit www.indianabiosciences.org.